Lancet Infect Dis

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden.

Marking U, Bladh O, Aguilera K, ..., Sheward DJ, Thålin C

Lancet Infect Dis 24 (2) e80-e81 [2024-02-00; online 2024-01-05]

Affinity Proteomics Uppsala [Collaborative]

Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responses.

Sheward DJ, Yang Y, Westerberg M, ..., Albert J, Murrell B

Lancet Infect Dis 23 (11) e462-e463 [2023-11-00; online 2023-09-27]

Clinical Genomics [Service] Clinical Genomics Stockholm [Service]

SARS-CoV-2-related mortality decrease in nursing home residents given multiple COVID-19 boosters.

Blom K, Fjällström P, Molnár C, ..., Forsell MNE, Johansson AF

Lancet Infect Dis 23 (10) e393-e394 [2023-10-00; online 2023-09-13]

Affinity Proteomics Uppsala [Collaborative]

Mucosal IgA protects against BQ.1 and BQ.1.1 infection.

Marking U, Bladh O, Havervall S, ..., Klingström J, Thålin C

Lancet Infect Dis 23 (8) e272-e273 [2023-08-00; online 2023-07-12]

Affinity Proteomics Uppsala [Collaborative]

7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection.

Marking U, Bladh O, Havervall S, ..., Klingström J, Thålin C

Lancet Infect Dis 23 (2) 150-152 [2023-02-00; online 2023-01-11]

Affinity Proteomics Uppsala [Collaborative]

Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies.

Sheward DJ, Kim C, Fischbach J, ..., Peacock TP, Murrell B

Lancet Infect Dis 22 (11) 1538-1540 [2022-11-00; online 2022-10-14]

Clinical Genomics [Service] Clinical Genomics Stockholm [Service]

Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection.

Blom K, Marking U, Havervall S, ..., Klingström J, Thålin C

Lancet Infect Dis 22 (7) 943-945 [2022-07-00; online 2022-06-09]

Affinity Proteomics Uppsala [Collaborative] Autoimmunity and Serology Profiling [Collaborative]